1989•PubMedRequires access

[Treatment of supraventricular paroxysmal tachycardia by intravenous administration of ATP].

Iu I Nesterov, Kiselev Ag, L I Suvorova, Trushina Ts, Boĭko Vi

Open publisher page 0 citations

Abstract

The results of treatment of supraventricular paroxysmal tachycardia by the intravenous administration of ATP in a dose of 10-30 mg make it possible to consider ATP as an agent of choice for relieving supraventricular paroxysmal tachycardia under conditions of emergency medical aid.

About this research paper

What this paper is about

The results of treatment of supraventricular paroxysmal tachycardia by the intravenous administration of ATP in a dose of 10-30 mg make it possible to consider ATP as an agent of choice for relieving supraventricular paroxysmal tachycardia under conditions of emergency medical aid.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The results of treatment of supraventricular paroxysmal tachycardia by the intravenous administration of ATP in a dose of 10-30 mg make it possible to consider ATP as an agent of choice for relieving supraventricular paroxysmal tachycardia under conditions of emergency medical aid.

Key concepts: Paroxysmal supraventricular tachycardia, Medicine, Tachycardia, Supraventricular tachycardia, Anesthesia, Paroxysmal tachycardia, Cardiology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
[Treatment of supraventricular paroxysmal tachycardia by intravenous administration of ATP]. — Research Paper | ScholarLens